Publications

Recherche

Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique (CRMR SNI) - Nice

logo tel   04 92 03 79 17   logo mail   Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.
frendeites

Vous trouverez ci-dessous la liste des publications du CRMR Syndrome Néphrotique Idiopathique (SNI) de Nice sur la thématique du SNI depuis 2012.

PATHOLOGIE ANNEE PUBLICATION LIEN
Glomérulonéphrite Extra-Membraneuse 2021 Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy.
Teisseyre M, Boyer-Suavet S, Crémoni M, Brglez V, Esnault V, Seitz-Polski B. Kidney Int Rep. 2021 Jan
PubMed
Glomérulonéphrite Extra-Membraneuse 2021 Growing Understanding of the Antigenic Basis for Membranous Nephropathy.
Brglez V, Seitz-Polski B. Clin J Am Soc Nephrol. 2021 May
PubMed
Glomérulonéphrite Extra-Membraneuse 2020 Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.
Cremoni M, Brglez V, Perez S, Decoupigny F, Zorzi K, Andreani M, Gérard A, Boyer-Suavet S, Ruetsch C, Benzaken S, Esnault V, Seitz-Polski B. Front Immunol. 2020 Nov
PubMed
Glomérulonéphrite Extra-Membraneuse 2020 Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM, Seitz-Polski B, Justino J, Zaghrini C, Payré C, Brglez V, Dolla G, Sinico A, Scolari F, Vaglio A, Prunotto M, Candiano G, Radice A, Bruschi M, Lambeau G; Italian Study Group for Membranous Nephropathy. Clin J Am Soc Nephrol. 2020 Dec
PubMed
Syndrome Néphrotique Idiopathique de l'enfant 2020 Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial.
Hogan J, Perez A, Sellier-Leclerc AL, Vrillon I, Broux F, Nobili F, Harambat J, Bessenay L, Audard V, Faudeux C, Morin D, Pietrement C, Tellier S, Djeddi D, Eckart P, Lahoche A, Roussey-Kesler G, Ulinski T, Boyer O, Plaisier E, Cloarec S, Jolivot A, Guigonis V, Guilmin-Crepon S, Baudouin V, Dossier C, Deschênes G. BMJ Open. 2020 Sep
PubMed
Glomérulonéphrite Extra-Membraneuse 2020 Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial.
Brglez V, Boyer-Suavet S, Zorzi K, Fernandez C, Fontas E, Esnault V, Seitz-Polski B. Front Med (Lausanne). 2020 Aug
PubMed
Glomérulonéphrite Extra-Membraneuse 2020 Complement Pathways in Membranous Nephropathy: Complex and Multifactorial.
Brglez V, Boyer-Suavet S, Seitz-Polski B. Kidney Int Rep. 2020 Mar
PubMed
Glomérulonéphrite Extra-Membraneuse 2019 Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab.
Boyer-Suavet S, Andreani M, Lateb M, Savenkoff B, Brglez V, Benzaken S, Bernard G, Nachman PH, Esnault V, Seitz-Polski B. Front Immunol. 2020 Jan

PubMed

Glomérulonéphrite Extra-Membraneuse 2019 Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation.
Lateb M, Ouahmi H, Payré C, Brglez V, Zorzi K, Dolla G, Zaidan M, Boyer-Suavet S, Knebelmann B, Crépin T, Courivaud C, Jourde-Chiche N, Esnault V, Lambeau G, Seitz-Polski B. J Immunol Res. 2019 Dec
PubMed
Glomérulonéphrite Extra-Membraneuse 2019 High-dose rituximab and early remission in PLA2R1-related membranous nephropathy. Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM. Clin J Am Soc Nephrol. 2019 Aug

PubMedCJASNVisual Abstract

Syndrome Néphrotique Idiopathique de l'enfant 2019 Nephrotic syndrome and mitochondrial disorders: Answers. Bernardor J, Faudeux C, Chaussenot A, Antignac C, Goldenberg A, Gubler MC, Wagner N, Bérard E. Pediatr Nephrol. 2019 Aug PubMed
Syndrome Néphrotique Idiopathique de l'enfant 2019 Nephrotic syndrome and mitochondrial disorders: Questions. Bernardor J, Faudeux C, Chaussenot A, Antignac C, Goldenberg A, Gubler MC, Wagner N, Bérard E. Pediatr Nephrol. 2019 Aug PubMed
Glomérulonéphrite Extra-Membraneuse 2019 Rituximab bioavailability in primary membranous nephropathy. Boyer-Suavet S, Andreani M, Cremoni M, Brglez V, Benzaken S, Bernard G, Nachman P, Esnault V, Seitz-Polski B. Nephrol Dial Transplant. 2019 Mar PubMed
Glomérulonéphrite Extra-Membraneuse 2019 Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy. Zaghrini C, Seitz-Polski B, Justino J, Dolla G, Payré C, Jourde-Chiche N, Van de Logt AE, Booth C, Rigby E, Lonnbro-Widgren J, Nystrom J, Mariat C, Cui Z, Wetzels JFM, Ghiggeri G, Beck LH Jr, Ronco P, Debiec H, Lambeau G. Kidney Int. 2019 Mar PubMed
Syndrome Néphrotique Idiopathique de l'adulte 2018 An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study). Rémy P, Audard V, Natella PA, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Ait Sahlia N, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D; MSN Trial Investigators. Kidney Int. 2018 Dec PubMed
Glomérulonéphrite Extra-Membraneuse 2018 Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy. Seitz-Polski B, Debiec H, Rousseau A, Dahan K, Zaghrini C, Payré C, Esnault VLM, Lambeau G, Ronco P. J Am Soc Nephrol. 2018 Feb PubMed
Glomérulopathies 2018 [Glomerular diseases in brief]. Andreani M, Esnault V. Rev Prat. 2018 Jan PubMed
Néphropathies Glomérulaires 2018 [Glomerular nephropathy]. Andreani M, Esnault V. Rev Prat. 2018 Jan PubMed
Syndrome Néphrotique Idiopathique de l'enfant 2017 [Idiopathic nephrotic syndrome]. Boyer O, Baudouin V, Bérard E, Dossier C, Audard V, Guigonis V, Vrillon I. Arch Pediatr. 2017 Dec PubMed
Syndrome Néphrotique Idiopathique de l'enfant 2017 [Treatments of steroid-dependent nephrotic syndrome in children]. Couderc A, Bérard E, Guigonis V, Vrillon I, Hogan J, Audard V, Baudouin V, Dossier C, Boyer O. Arch Pediatr. 2017 Dec PubMed
Glomérulonéphrite Extra-Membraneuse 2017 [Membranous nephropathy: Pathophysiology and natural history]. Seitz-Polski B, Lambeau G, Esnault V. Nephrol Ther. 2017 Apr PubMed
Glomérulonéphrite Extra-Membraneuse 2017 Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy. Jullien P, Seitz Polski B, Maillard N, Thibaudin D, Laurent B, Ollier E, Alamartine E, Lambeau G, Mariat C. Clin Kidney J. 2017 Apr PubMed
Glomérulonéphrite Extra-Membraneuse 2016 Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. Seitz-Polski B, Dolla G, Payré C, Girard CA, Polidori J, Zorzi K, Birgy-Barelli E, Jullien P, Courivaud C, Krummel T, Benzaken S, Bernard G, Burtey S, Mariat C, Esnault VL, Lambeau G. J Am Soc Nephrol. 2016 May

PubMed

Glomérulonéphrite Extra-Membraneuse 2015 Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy. Seitz-Polski B, Dolla G, Payré C, Tomas NM, Lochouarn M, Jeammet L, Mariat C, Krummel T, Burtey S, Courivaud C, Schlumberger W, Zorzi K, Benzaken S, Bernard G, Esnault VL, Lambeau G. Biochimie. 2015 Nov

PubMed

Glomérulonéphrite Membraneuse 2015 C3 nephritic factor can be associated with membranous glomerulonephritis. Niel O, Dallocchio A, Thouret MC, Guigonis V, Cassuto É, Frémeaux-Bacchi V, Bérard É. Pediatr Nephrol. 2015 Feb PubMed
Glomérulonéphrite Extra-Membraneuse 2014 Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RAK, Lambeau G. N Engl J Med. 2014 Dec PubMed
Glomérulonéphrite Extra-Membraneuse 2014 Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients. Seitz-Polski B, Payré C, Ambrosetti D, Albano L, Cassuto-Viguier E, Berguignat M, Jeribi A, Thouret MC, Bernard G, Benzaken S, Lambeau G, Esnault VL. Nephrol Dial Transplant. 2014 Dec PubMed
Glomérulonéphrite Extra-Membraneuse 2014 [New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy]. Girard CA, Seitz-Polski B, Dolla G, Augert A, Vindrieux D, Bernard D, Lambeau G. Med Sci (Paris). 2014 May PubMed
Glomérulonéphrite Extra-Membraneuse 2013 Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W. Clin Chim Acta. 2013 Jun

PubMed